Drugs by medical condition enlist drugs according to the disease states.
Melatonin is a hormone primarily produced by the pineal gland in the brain. It plays a critical role in regulating sleep-wake cycles, often referred to as the circadian rhythm. The production of melatonin is influenced by light exposure; during the day, light inhibits melatonin secretion, resulting in lower levels of the hormone. Conversely, as darkness … Read more
Rapiblyk, commercially known as landiolol, is an innovative short-acting beta-adrenergic blocker that has garnered attention for its specific applications in cardiac care. As of 2024, Rapiblyk has been officially approved for use in the United States, introducing a new therapeutic option for healthcare providers managing patients with certain cardiovascular conditions. Its efficacy and rapid onset … Read more
Itovebi is a potent kinase inhibitor that has gained attention in the treatment landscape for advanced breast cancer, particularly when used in combination with other therapeutic agents like palbociclib and fulvestrant. Its primary indication lies in targeting specific breast cancer subtypes, notably endocrine-resistant, PI3KCA-mutated, HR-positive, and HER2-negative breast cancer in adult patients. This specificity is … Read more
Lazcluze (Lazertinib) is the latest medical breakthrough in the ongoing fight against non-small cell lung cancer (NSCLC). Officially approved by the Food and Drug Administration (FDA) on August 19, 2024, Lazcluze offers a novel therapeutic option for patients diagnosed with this aggressive and often difficult-to-treat form of cancer. Its advent marks a significant milestone in … Read more
Can a new treatment change the lives of those living with vitiligo? The recent TRuE-V1 Study suggests it can. Vitiligo, a chronic skin condition that causes white patches due to pigment loss, has long had limited treatment options. A new clinical trial, the Topical Ruxolitinib Evaluation in VItiligo Study 1 (TRuE-V1), has revealed a game-changing … Read more
BEOVU Indications: Wet age-related macular degeneration Brand Name: Beovu Drug Name: Brolucizumab Date of FDA Approval: 8th Oct 2019 Manufacturer: Novartis Pharmaceuticals [Ref] BEOVU® (Brolucizumab-dbll) injection is a medication that has been recently approved by the FDA for the treatment of wet age-related macular degeneration (AMD). It is one of the new molecules that block … Read more
Irritable Bowel Syndrome (IBS) is the most common gastrointestinal disorder. Many over-the-counter treatment options are now available to ease the unpleasant symptoms of IBS. But it often gets confusing to choose the right medicine according to your IBS type. A gastrointestinal (GI) illness called irritable bowel syndrome (IBS) is characterized by recurring episodes of abdominal … Read more
Tirzepatide is a dual GLP-1 and GIP analog that has got FDA approval for the treatment of patients with Type 2 Diabetes Mellitus. It has been associated with marked weight loss of approximately 22% which is even greater than Wegovy, an FDA-approved weight loss drug, however, Tirzepatide’s FDA approval as a weight loss drug is … Read more
Biologics for Psoriasis are used in patients who have moderate to severe disease or are not responsive to conventional therapies. Biologics for psoriasis are both effective and tolerable. They have good short-term and long-term efficacy. The most common side effect associated with the use of biologics for psoriasis is the increased incidence of infections. TNF-alpha … Read more
Methocarbamol (Robaxin) is a centrally acting drug that is primarily used to relieve muscle spasms. It has not been studied in patients with anxiety, insomnia, and depression, since it does not have any effect on the GABA, serotonin, or nor-epinephrine central pathways. Primary Uses of Methocarbamol (Robaxin): Methocarbamol (Robaxin) is primarily used in the treatment … Read more